HALIX is a biologics CDMO based in Leiden, Netherlands, specializing in end-to-end development and GMP manufacturing of viral vectors, vaccines, and recombinant proteins. The company operates a 6,700 square meter cGMP facility at the Leiden Bio Science Park with 10 clean rooms and 7 bioreactors. HALIX successfully manufactured the AstraZeneca COVID-19 vaccine at commercial scale and serves over 75 customers with a 90% retention rate.
viral vector manufacturing, recombinant protein production, vaccine manufacturing, mammalian cell culture, aseptic fill/finish and lyophilization
1 site worldwide
No reviews available yet.
No documents available.